{"id":43589,"date":"2026-09-04T15:07:21","date_gmt":"2026-09-04T15:07:21","guid":{"rendered":"https:\/\/eurekainfomed.it\/en\/?p=43589"},"modified":"2026-09-04T15:07:21","modified_gmt":"2026-09-04T15:07:21","slug":"validation-of-pharmaceutical-promotional-materials","status":"publish","type":"post","link":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/","title":{"rendered":"Validation of Pharmaceutical Promotional Materials"},"content":{"rendered":"

A claim that is not fully supported, a citation taken out of context, or an outdated version of the SmPC can turn an effective material into a source of regulatory and reputational risk. Validation of pharmaceutical promotional materials<\/strong> is therefore not an administrative step performed at the end of content development. It is the process that ensures consistency between evidence, messages, target channels, and corporate responsibility.<\/p>\n

\n

For Medical Affairs, Regulatory Affairs, Quality Assurance, and Marketing, the challenge is not simply obtaining approval for a visual aid, a webpage, or a digital campaign. The challenge is being able to demonstrate, even years later, why that content was accurate, who it was intended for, which sources supported it, and which version was actually used. In this context, clarity is operational security.<\/p>\n

Validation of Pharmaceutical Promotional Materials: what it includes<\/h2>\n

Validation applies to all materials that communicate promotional information or messages relating to a medicinal product, including sales force materials, brochures, print advertisements, website and portal content, emails, banners, congress materials, webinars, videos, social media content, and digital tools intended for healthcare professionals. The scope may also include so-called non-promotional materials when the boundary between scientific information, corporate communication, and promotion requires careful assessment.<\/p>\n

The first point to clarify is the intended audience. Content aimed at physicians, pharmacists, or other healthcare professionals is subject to different requirements than content intended for the general public. The level of detail, mandatory information, communication possibilities, and dissemination methods differ. For prescription medicines, communication to the public is subject to particularly strict limitations; for materials intended for healthcare professionals, accuracy, balance, and consistency with approved information remain essential requirements.<\/p>\n

The review process must also consider applicable national legislation, requirements from competent authorities, industry and ethical codes, company procedures, and any local requirements applicable to multichannel or multinational projects. A workflow developed for one market cannot simply be transferred to another without dedicated regulatory review.<\/p>\n

Promotional, informational, or corporate: classification comes first<\/h2>\n

Many issues arise from an incomplete initial classification. Content may appear educational or intended for disease awareness but contain elements that, due to tone, context, call to action, or reference to a product, bring it closer to promotion. Even a medical-scientific document can become problematic if it selectively presents favorable data without adequately describing limitations, study populations, or clinical relevance.<\/p>\n

Classification should not be treated as a formality. It determines the approval pathway, the functions involved, the sources required, the necessary disclaimers, and the archiving process. When there is uncertainty regarding interpretation, it is preferable to document the rationale before the material enters the execution phase.<\/p>\n

Reviews that protect Quality and Compliance<\/h2>\n

Effective validation requires the integration of multiple areas of expertise. Review of the text by a single function is rarely sufficient, particularly for materials that combine clinical claims, safety data, graphical elements, therapeutic comparisons, and usage instructions.<\/p>\n

The core of the process is verifying consistency with the Summary of Product Characteristics, the package leaflet where applicable, and other approved documents. Indications, populations, dosage, contraindications, warnings, interactions, efficacy data, and safety information must be presented without unsupported interpretative extensions. Seemingly small wording choices matter. An absolute adverb, a superlative, or omission of a study condition may alter the meaning of a claim.<\/p>\n

Medical-scientific review assesses source quality, bibliography relevance, and the accurate interpretation of study findings. It is not sufficient that the cited article exists. The study design, endpoints, population, sample size, methodological limitations, statistical significance, and applicability of the findings to the proposed message must all be evaluated. Particular caution is required for direct or indirect comparisons, as comparability between studies cannot be assumed.<\/p>\n

Regulatory review verifies compliance with requirements applicable to the target audience and communication channel, as well as alignment with approval and dissemination procedures. Legal review may be required for comparative claims, materials with contractual implications, campaigns involving personal data, or initiatives carrying significant reputational exposure. Quality Assurance contributes by ensuring that the process is controlled, repeatable, and inspection-ready.<\/p>\n

Pharmacovigilance: a control element to integrate into the material<\/h2>\n

Pharmacovigilance does not become relevant only after content is published. During the validation phase, it is necessary to assess whether the material includes up-to-date safety information and whether the selected channels allow for the proper management of potential adverse event reports or medical information requests.<\/p>\n

This aspect becomes particularly important for digital channels, where comments, private messages, contact forms, and interactions during online events may generate relevant touchpoints. Materials should therefore be accompanied by clear internal instructions specifying who monitors the channel, how escalation occurs, expected response timelines, and how medical information requests are distinguished from potential safety reports.<\/p>\n

A traceable workflow: from request to archive<\/h2>\n

The quality of validation also depends on how the work is organized. The process should begin with a structured brief that includes the product, indication, target audience, purpose, channel, country, intended use date, available references, and project owners. Without this information, reviewers often receive drafts that require multiple clarification cycles and increase the risk of inconsistencies.<\/p>\n

The next step is content development, ideally supported by medical writing and literature research proportionate to the complexity of the message. Every significant claim should be traceable to an identifiable source or approved document. Sources must be up to date, accessible, and maintained according to internal document management requirements, rather than being referenced only generically within the layout.<\/p>\n

The review phase requires clearly defined roles. Medical, Regulatory, Marketing, Legal, Pharmacovigilance, and QA teams do not necessarily need to participate with the same level of involvement for every material. A simple graphic update, for example, may follow a streamlined pathway if it does not alter content, audience, or channel. By contrast, a new claim, an indication extension, or an omnichannel campaign requires a more extensive multidisciplinary review.<\/p>\n

Approval does not mark the end of the process. It is necessary to ensure that the approved version is the one actually used, that all required information remains legible in the final format, and that expired or superseded materials are withdrawn. Version control, electronic approvals, audit trails, source archives, and validity dates make it possible to reconstruct the complete history of a document during an audit, inspection, or internal review.<\/p>\n

Critical issues in digital channels<\/h2>\n

In digital communications, controlling text alone is not sufficient. A claim approved within a PDF may become non-compliant if shortened for a social media post, placed next to misleading imagery, displayed incompletely on a mobile device, or republished after an SmPC update. Short and dynamic formats require dedicated planning rather than simple adaptation of print materials.<\/p>\n

Particular attention should be paid to landing pages, email automation, modular content, programmatic campaigns, and assets shared by third parties. Each element may be updated, combined, or distributed according to different timelines. For this reason, it can be useful to establish a content matrix linking each asset to its audience, purpose, version, sources, approvers, validity period, and usage rules.<\/p>\n

The use of content generated or adapted using automated tools requires qualified human oversight. Such tools may accelerate drafting and adaptation activities, but they do not replace clinical, regulatory, and contextual review. The risk extends beyond factual inaccuracies and includes loss of nuance, use of unverifiable sources, and absence of documented rationale.<\/p>\n

When to outsource validation<\/h2>\n

Outsourcing can be beneficial when the volume of materials exceeds internal capacity, when specialized expertise is required on a non-continuous basis, or when continuity must be maintained during launches, congresses, regulatory updates, and periods of increased activity. This does not mean transferring corporate responsibility. Rather, it means extending the team with qualified resources capable of operating according to shared procedures.<\/p>\n

An appropriate partner should be able to integrate medical writing, literature research, regulatory affairs, pharmacovigilance, quality assurance, and document management. Speed alone is not a measure of effectiveness. A rapid review adds value only if it maintains traceability, clear responsibilities, and high-quality evidence. Eureka InfoMed supports this integrated approach, adapting the level of support to the needs of pharmaceutical, biotech, and medtech companies without separating scientific content from its regulatory context.<\/p>\n

A well-validated promotional material does not limit communication. It provides it with verifiable foundations. When sources, messages, approvals, and channels are managed systematically, teams can focus on what the material is ultimately intended to do: provide accurate information, support informed clinical decisions, and protect trust in both the product and the company.<\/p>\n

Sources<\/h2>\n
    \n
  1. European Federation of Pharmaceutical Industries and Associations (EFPIA). EFPIA Code of Practice<\/em>.<\/li>\n
  2. Farmindustria. Farmindustria Code of Ethics<\/em>.<\/li>\n
  3. Italian Medicines Agency (AIFA). Regulations on the Advertising of Medicinal Products for Human Use<\/em>.<\/li>\n
  4. European Medicines Agency (EMA). Product Information: Summary of Product Characteristics (SmPC) and Package Leaflet Guidance<\/em>.<\/li>\n<\/ol>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    A claim that is not fully supported, a citation taken out of context, or an outdated version of the SmPC can turn an effective material into a source of regulatory…<\/p>\n","protected":false},"author":16,"featured_media":43590,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-43589","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news"],"yoast_head":"\nValidation of Pharmaceutical Promotional Materials - Eureka Info Med<\/title>\n<meta name=\"description\" content=\"Learn how pharmaceutical promotional materials are reviewed to ensure regulatory compliance, scientific accuracy, pharmacovigilance oversight\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Validation of Pharmaceutical Promotional Materials - Eureka Info Med\" \/>\n<meta property=\"og:description\" content=\"Learn how pharmaceutical promotional materials are reviewed to ensure regulatory compliance, scientific accuracy, pharmacovigilance oversight\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/\" \/>\n<meta property=\"og:site_name\" content=\"Eureka Info Med\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-04T15:07:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/09\/validazione-materiali-promozionali-farmaceutici-featured-768x512-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"768\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"EleonoraHay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"EleonoraHay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/\"},\"author\":{\"name\":\"EleonoraHay\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/a7fea1f3cb636f2ae5986e9a8e805f55\"},\"headline\":\"Validation of Pharmaceutical Promotional Materials\",\"datePublished\":\"2026-09-04T15:07:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/\"},\"wordCount\":1436,\"image\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/validazione-materiali-promozionali-farmaceutici-featured-768x512-1.webp\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/\",\"name\":\"Validation of Pharmaceutical Promotional Materials - Eureka Info Med\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/validazione-materiali-promozionali-farmaceutici-featured-768x512-1.webp\",\"datePublished\":\"2026-09-04T15:07:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/a7fea1f3cb636f2ae5986e9a8e805f55\"},\"description\":\"Learn how pharmaceutical promotional materials are reviewed to ensure regulatory compliance, scientific accuracy, pharmacovigilance oversight\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/validazione-materiali-promozionali-farmaceutici-featured-768x512-1.webp\",\"contentUrl\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/validazione-materiali-promozionali-farmaceutici-featured-768x512-1.webp\",\"width\":768,\"height\":512},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/validation-of-pharmaceutical-promotional-materials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Validation of Pharmaceutical Promotional Materials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/\",\"name\":\"Eureka Info Med\",\"description\":\"documentazione medico-scientifica e farmacovigilanza\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/#\\\/schema\\\/person\\\/a7fea1f3cb636f2ae5986e9a8e805f55\",\"name\":\"EleonoraHay\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g\",\"caption\":\"EleonoraHay\"},\"url\":\"https:\\\/\\\/eurekainfomed.it\\\/en\\\/author\\\/eleonorahay\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Validation of Pharmaceutical Promotional Materials - Eureka Info Med","description":"Learn how pharmaceutical promotional materials are reviewed to ensure regulatory compliance, scientific accuracy, pharmacovigilance oversight","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/","og_locale":"en_US","og_type":"article","og_title":"Validation of Pharmaceutical Promotional Materials - Eureka Info Med","og_description":"Learn how pharmaceutical promotional materials are reviewed to ensure regulatory compliance, scientific accuracy, pharmacovigilance oversight","og_url":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/","og_site_name":"Eureka Info Med","article_published_time":"2026-09-04T15:07:21+00:00","og_image":[{"width":768,"height":512,"url":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/09\/validazione-materiali-promozionali-farmaceutici-featured-768x512-1.webp","type":"image\/webp"}],"author":"EleonoraHay","twitter_card":"summary_large_image","twitter_misc":{"Written by":"EleonoraHay","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/#article","isPartOf":{"@id":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/"},"author":{"name":"EleonoraHay","@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/a7fea1f3cb636f2ae5986e9a8e805f55"},"headline":"Validation of Pharmaceutical Promotional Materials","datePublished":"2026-09-04T15:07:21+00:00","mainEntityOfPage":{"@id":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/"},"wordCount":1436,"image":{"@id":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/#primaryimage"},"thumbnailUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/09\/validazione-materiali-promozionali-farmaceutici-featured-768x512-1.webp","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/","url":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/","name":"Validation of Pharmaceutical Promotional Materials - Eureka Info Med","isPartOf":{"@id":"https:\/\/eurekainfomed.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/#primaryimage"},"image":{"@id":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/#primaryimage"},"thumbnailUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/09\/validazione-materiali-promozionali-farmaceutici-featured-768x512-1.webp","datePublished":"2026-09-04T15:07:21+00:00","author":{"@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/a7fea1f3cb636f2ae5986e9a8e805f55"},"description":"Learn how pharmaceutical promotional materials are reviewed to ensure regulatory compliance, scientific accuracy, pharmacovigilance oversight","breadcrumb":{"@id":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/#primaryimage","url":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/09\/validazione-materiali-promozionali-farmaceutici-featured-768x512-1.webp","contentUrl":"https:\/\/eurekainfomed.it\/en\/wp-content\/uploads\/2026\/09\/validazione-materiali-promozionali-farmaceutici-featured-768x512-1.webp","width":768,"height":512},{"@type":"BreadcrumbList","@id":"https:\/\/eurekainfomed.it\/en\/validation-of-pharmaceutical-promotional-materials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eurekainfomed.it\/en\/"},{"@type":"ListItem","position":2,"name":"Validation of Pharmaceutical Promotional Materials"}]},{"@type":"WebSite","@id":"https:\/\/eurekainfomed.it\/en\/#website","url":"https:\/\/eurekainfomed.it\/en\/","name":"Eureka Info Med","description":"documentazione medico-scientifica e farmacovigilanza","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eurekainfomed.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/eurekainfomed.it\/en\/#\/schema\/person\/a7fea1f3cb636f2ae5986e9a8e805f55","name":"EleonoraHay","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4d69f2b5701b09e9eb5e59e8f2826c37ad6c9c89c09b3542f5773a6e61157663?s=96&d=mm&r=g","caption":"EleonoraHay"},"url":"https:\/\/eurekainfomed.it\/en\/author\/eleonorahay\/"}]}},"_links":{"self":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/43589","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/comments?post=43589"}],"version-history":[{"count":1,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/43589\/revisions"}],"predecessor-version":[{"id":43591,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/posts\/43589\/revisions\/43591"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/media\/43590"}],"wp:attachment":[{"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/media?parent=43589"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/categories?post=43589"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurekainfomed.it\/en\/wp-json\/wp\/v2\/tags?post=43589"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}